Clear Search

About BCRF

The Breast Cancer Research Foundation is a nonprofit organization committed to achieving prevention and a cure for breast cancer. We provide critical funding for cancer research worldwide to fuel advances in tumor biology, genetics, prevention, treatment, metastasis and survivorship.

 

a-rated-organization.202ee33

Since our founding in 1993 by Evelyn H. Lauder, BCRF has raised more than a billion dollars to fuel its mission to be the end of breast cancer. Through a unique and streamlined grants program, we seek out the brightest minds in science and medicine and give them the necessary resources to pursue their best ideas. This enables researchers to make discoveries and design new approaches to address all aspects of breast cancer—and do so in record time.

In 2023-2024, BCRF will award $60.2 million in annual grants to more than 250 scientists from top universities and medical institutions around the globe. In addition, BCRF has established the Evelyn H. Lauder Founder’s Fund, a multi-year international program to unravel the biology of metastasis. It is the largest privately funded project exclusively focused on metastasis in the world.

The thousands of women and men suffering from breast cancer today depend on us. No institution can conquer this disease alone. Together, we can.

Our History

It all started in 1993 at Evelyn Lauder’s kitchen table. Over a cup of coffee, Mrs. Lauder and her dear friend Dr. Larry Norton began a conversation that would change breast cancer history. Recognizing the power of research and its potential to change the lives of millions of women and men worldwide, they realized that a new approach was critical to tackle breast cancer.

Learn More

Our People

OUR TEAM

Day in and day out, BCRF staff work to end breast cancer.

BOARD OF DIRECTORS

These experts in their fields lend their leadership to BCRF.

SCIENTIFIC ADVISORS

This board of world-renowned investigators shapes our grants program.

MAJOR DONORS

Thanks to their generosity, BCRF can support more than 250 investigators worldwide.